Author:
Peters Godefridus J.,Adema Auke D.,Bijnsdorp Irene V.,Sandvold Marit L.
Subject
Genetics,Molecular Medicine,Biochemistry,General Medicine
Reference48 articles.
1. Determinants of resistance to 2′,2′-difluorodeoxycytidine (gemcitabine)
2. Hubeek, I., Kaspers, G. J., Ossenkoppele, G. J. and Peters, G. J. 2006.Cancer Drug Discovery and Development: Deoxynucleoside Analogs in Cancer Therapy, Edited by: Peters, G. J. 119–152. Totowa, NJ: Humana Press. Cytosine arabinoside: Metabolism, mechanisms of Resistance, and clinical pharmacology, in
3. Peters, G. J. and Jansen, G. 1996.Principles of Antineoplastic Drug Development and Pharmacology, Edited by: Schilsky, R. L., Milano, G. A. and Ratain, M. J. 543–585. New York: Marcel Dekker. Clinical pharmacokinetics of anti-metabolites, in
4. Innovations and Opportunities to Improve Conventional (Deoxy)Nucleoside and Fluoropyrimidine Analogs in Cancer
Cited by
9 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献